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ABSTRACT
The ospA gene from a North American strain of the Lyme disease Spirochete, Borrelia butgdorferi, has
been cloned under the control of transcription and translation signals from bacteriophage T7. Full-length OspA
protein, a 273 amino acid (31kD) lipoprotein, is expressed poorly in Escherichia coli and is associated with the
insoluble membrane fraction. In contrast, a truncated form of OspA lacking the amino-terminal signal sequence
which normally would direct localization of the protein to the outer membrane is expressed at very high levels
(> 100rag/liter) and is soluble. The truncated protein has been purified to homogeneity and is being tested to
see if it will be useful as an immunogen in a vaccine against Lyme disease. Circular dichroism and fluorescence
spectroscopy has been used to characterize the secondary structure and study conformational changes in the
protein. Studies underway with other surface proteins from B. burgdorferi and a related spirochete, B. hermsii,
which causes relapsing fever, leads us to conclude that a strategy similar to that used to express the truncated
OspA can provide a facile method for producing variations of Borrelia lipoproteins which are highly expressed
in E. coli and soluble without exposure to detergents.
INTRODUCTION
Lyme disease is caused by the spirochete Borrelia burgdorferi and this complex disorder is the most
common vector-borne infection in the USA. Specific diagnostic tests and ultimately a vaccine for Lyme disease
are of major importance. In this regard, the outer surface lipoproteins (OspA and OspB) are of interest because
they are unique to B. burgdorferi and not shared with other Borrelia or spirochetes. These proteins are highly
immunogenic in experimental animals, however, the antibody response to these antigens occurs late in the course
of natural infection and only in a small minority of patients (<5%) [1-3]. While the exact functions of these
proteins are unknown, Osp-enriched fractions have been ut_ized as immunodiagnostics for late disease and in
the design of "selective Westerns'. The genes for these two proteins (ospA & ospB) are encoded in tandem in
a 2KB stretch of a 49 kB linear plasmid separated one from the other by only 12 base pairs and co-transcribed
from the same promoter [4, 5]. The deduced amino acid sequences of OspA and OspB begin with N-terminal
sequences believed to constitute signal sequences which normally direct localization of the protein products to
the spirochetes outer membrane.
We have chosen OspA as a model system for studying expression of B. burgdorferi proteins, particularly
surface proteins, in E. coil These proteins most likely affect the antigenicity, immunological reactivity, host cell
interactions of the spirochete, invasion of the host, and development of symptoms; information about these
proteins is expected to be useful in the diagnosis, treatment and prevention of the disease. Our goal is to use
recombinant DNA techniques to overexpress these proteins to standardize immunoassays and other diagnostic
screening tests and to serve as potential antigens for a vaccine.
METHODS
T7/pET system
B. burgdorferi OspA protein was expressed using the T7/pET expression system developed at
Brooldaaven [6] in which the RNA polymerase of bacteriophage T7 is used to drive transcription of a cloned
target sequence. Bacteriophage T7 RNA polymerase is a single-polypeptide enzyme that is highly selective for
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specific promoters that are rarely encountered in DNA unrelated to T7 DNA. Efficient termination signals are
also rare, so Ihat T7 RNA polymerase is able to make complete transcripts of almost any DNA that is placed
under control of a T7 promoter. A very active enzyme, T7 RNA polymerase elongates chains about five times
fastcr than does Escherichia coli RNA polymerase. These properties, together with the availability of the cloned
gcnc havc bccn cxploitcd as the basis of expression systems in E. coli and other cell types, including mammalian
and yeast cells.
Targct genes are cloncd in pET plasmids downstream from a strong T7 promoter and adjacent to
cfficicnt translational initiation signals from the phage. A host strain containing a chromosomal copy of the gene
for T7 RNA polymcrasc under control of the IPTG-inducible lacUV5 promoter is used for protein production.
The T7 polymerase is so selective and active that, after IPTG induction, almost all of the cell's resources are
converted to targct gene expression; after a few hours, the desired protein product can constitute more than 50%
of thc total cell protein. The host strain we use, BL21(DE3)/pLysS, also contains a plasmid which specifies low
levcls of T7 lysozyme, a natural inhibitor of T7 RNA polymerase. In uninduced cells, lysozyme reduces thebasal
activity of the T7 RNA polymerase and increases the range of target genes that can be stably maintained in the
cxprcssion host. We used a pET vector, pET9 that has a kan gene, conferring resistance to the antibiotic
kanamycin, as the selcctable marker instead of the more commonly used pET vectors with a gene conferring
resistance to amplcillin, bla. Ampiciltin is not used durlng growth, so ampicil|0yl-target protein conjugates cannot
be formed. Such conjugates would complicate projected immunological studles[7]. The hos(Ei coli strain,
BL21, lacks the ornpT outer membrane protease that can degrade proteins during purification [8], and it is
deficient in the Ion protease that can degrade recombinant proteins as they are being synthesized [9].
Polymerase Chain Reaction
Polymerase chain reaction (PCR) technology [10] has made cloning of genes into the pET vectors
efficient and straightforward. Not only does PCR permit targeted amplification of specific DNA sequences
starting with very small quantities of template, but also it provides a n efficient means to fuse signals, such as new,
unique restriction sites, to the 5' and 3' ends of a target sequence. Synthetic oligonucleotide primers ar e designed
to be complcmentary to a limited portion, typically about 15 nucleotides, at each end of the target sequence and
to inciudc the desired restriction enzyme recognition sequences near their 5'- ends. During amplification the
DNA scqucnccs of the primers are incorporated into the product, thereby, allowing new sequence information
in the 5' ends of the primers to be fused to the target sequence. After cutting with the appropriate restriction
cndonuclcase, the resulting amplified DNA is ready for insertion directly into the pET expression plasmid. The
natural ATG initiation codon in the vector is part of an Ndel site (CA ITATG), so coding sequences are easily
inscrted dircctly at the initiation codon by including an appropriately positioned Ndel site in the forward PCR
primer. Other vectors in the pET set have an Ncol site (CICATGG) at their initiation codon in case the target
gcne has an Ndel site(s) in its sequence. PCR-mediated cloning also can be used to split a gene into regions
that code for individual domains and antigenic cpitopes and these segments can be expressed individually to
climinate cross-reacting antigenic domains. It is important to note that PCR amplification can be used to
eliminaie endogenous B. burgdorferi promoter signals in front of a protein coding sequence. In all likelihood
these prokaryotic promoters would be recognized by the host polymerase and the plasmids containing them
would be unstable due to significant levels of basal transcription of the foreign gene by E. coli RNA polymerase.
TOO high a level of unrcgulatcd basal expression probably explalns why lsaacs and Radoif [ii i were unable to
clone the cndoflageilar sheath protein gene from a related spirochete, Treponema pallidum, in E. coli if they
includcd the native promoter in front of the coding sequence.
RESULTS
We have used two sequence specific sets of oligonucleotide primers to amplify and clone related forms
of the ospA gene under the control of transcription and translation signals from T7 [12]. One set allowed the
entire ospA sequence to be cloned, while the other primed amplification of a truncated form of ospA lacking
the first 17 codons specified by the wild-type structural gene, i.e. the residues believed to act as a signal sequence
to direct association of OspA with the Borrelia membrane. On the basis of its similarity with E. coli signal
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sequences it seemed possible that the full-length OspA protein would be lipidated in E. coil and become
membrane associated. Typically such proteins have poor solubility properties and consequently detergents are
required to solubilize them.
The recombinant version of the full-length ospA gene was expressed at a low level, a few % of the total
protein, even when the coding sequence was placed under control of the strong transcription and translation
signals from bacteriophage T7 in the pET vector. The low level of expression presumably is due to the
accumulated toxic effects of OspA protein localizing at the E. coli cell membrane during expression and, as
expected, the full-length protein remains associated with the insoluble E. coli membrane fraction unless
solubilized by detergents. In contrast, the truncated form of the OspA protein lacking the 17 amino acid long
signal sequence is expressed at very high levels, greater than 50% of the total protein, and it is highly soluble.
We have developed an efficient procedure for purifying large amounts of recombinant OspA to homogeneity;
more than 100 mg of protein can be obtained from 1 liter of induced cells. The recombinant OspA is highly
soluble in aqueous solution (z 50 mg/ml) and it elutes from a gel filtration column as a monomer under
nondenaturing conditions. The molar extinction coefficient at 280 nm of purified OspA has been determined,
simplifying quantitation in immunological testing.
The recombinant protein begins with two amino acids from the vector (Met Ala) fused in frame to
Lysinel8 of the OspA sequence. Amino-terminal sequencing of purified protein demonstrates that the first
methionine residue is removed, therefore, the recombinant protein is referred to as OspA-257. Western blotting
demonstrated that, although the OspA-257 protein is missing a lipidated N-terminus, it still reacts with antibodies
present in the synovial fluid of a patient with Lyme-induced arthritis and is recognized by a variety of polyclonal
and monoclonal antibodies raised against whole B. burgdorferi cells. Thus, it seems highly likely that the protein
will be useful in immunochemical analysis for detection of Lyme disease.
We of course would like to know the three-dimensional structure of OspA since such information would
assist in elucidation of antigenic sites and eventually may lead to development of a peptide-based vaccine. X-ray
diffraction is still the only method for determining the exact three-dlmensional structure of proteins in the size
range of OspA and attempts to crystallize OspA are in progress. In lieu of a crystal structure, we are using other
methods to characterize the structure of OspA such as circular dichroism (CD) spectroscopy. Unlike X-ray
diffraction, CD can be applied to proteins in solution, under physiological conditions. Each type of secondary
structure is characterized by a distinctive CD spectrum, and recent work by Johnson [13] showed that when CD
spectra of proteins are extended below 200 nm to 178 nm, five types of secondary structure can be predicted with
accuracy comparable to X-ray diffraction: a-helix, anti-parallel B-sheet, parallel B-sheet, B-turns (all types) and
aperiodic structures (including random coil).
We used the CD spectrometer at the National Synchrotron Light Source at BNL to measure the CD
spectra of OspA to wavelengths as short as 175 nm; conventional CD spectrometers measure spectra reliably in
the wavelength region > 200 nm. The spectra were analyzed with a computer program supplied by C.W.
Johnson, Jr. This algorithm uses matrix techniques (singular value decomposition) and statistical procedures
(variable selection) to fit the CD spectra of the protein to a linear combination of orthogonal CD spectra derived
from a library of reference proteins, whose secondary structures are known from X-ray diffraction. The results
[14] show that OspA contains mostly B-sheet (27% antl-parallel, 9% parallel) configurations, B-turn (21%), and
random coil (34%), but little a-helix (11%). These values are quite different from those obtained using purely
predictive methods based solely on the amino acid sequence of OspA, which predict a much higher percent of
,,-helix than is present (Table 1).
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Description of
Method
UV-CD (our work)
Type of structure %
a-helix others
45 (40)
Garnier-Robson 54 (53)
8-aU
types
57±2
22 (21)
28 (34)
17 (18)
11±1 34±1
PCGene 24 (27)" 54 (52)
Chou-Fasman 27 (26)
29 (29)
" (predicted values for full-length, unprocessed OspA)
TABLE 1.
We have also used steady-state and time-resolved fluorescence to investigate the static and dynamic
aspects of OspA conformation. OspA contains a single tryptophan residue at position 200 (residue 216 in the
full-length protein). Tryptophan can be selectively excited at wavelengths z 295 nm and its fluorescence emission
is particularly sensitive to the local environment. The fluorescence signal provides a probe for changes in protein
conformation since changes in protein conformation are expected to cause changes in the environment of
tryptophan. The emission peak (330 nm) of OspA and its response to various ionic and nonionic quenchers
indicate that Trp200 is buried within the native protein in a relatively hydrophobic environment. Trp200 is
completely exposed to the solvent, as expected for a random coil, when OspA is denatured by high temperature
(z 8&C) or gnanidlne.
Both CD and fluorescence measurements reveal that the native conformation of OspA is highly stable;
no significant changes are seen from pH 3-11, and the protein is stable at low and high salt concentrations. The
protein returns to its native state, as reflected by CD and fluorescence measurements, after being held at 10&C
for up to 10 min. Interestingly, the OspA-257 protein is exceptionally resistant to digestion by trypsin and human
plasmin, even though it is rich in lysine residues (16 tool %) which are distributed rather uniformly throughout
the protein, but it is extremely susceptlblc to proteinase K.
The same strategy used to clone ospA was used to clone recombinant versions of ospB directly into a
pET vector with similar results, i.e. the full-length lipidated protein is poorly expressed while its truncated
counterpart is overproduced 1. The truncated OspB protein is currently being characterized by CD and
fluorescence; it also has a single tryptophan.
In a related spirochete, B. hennsii, antigenic variation is the consequence of sequential expression of
genes for a set of variable outer surface proteins known as Vmps [15]. Recently, it has been demonstrated that
the Vmp genes have many features in common with the B. burgdorferi Osp gene family including N-terminal
sequences that are typical of lipoproteins and evidence has been presented that the Vmp proteins are recognized
and processed as lil_oproteins in E. coli [16]. As might be expected, full-length Vmp's are expressed at relatively
low levels in E. coli z presumably because the protein is toxic when it becomes anchored in the membrane. Vmp
overproduction was possible if the region of the gene encoding the hydrophobic si_ignalsequence was excised
before the recombinant gene was placed under control of T7 signals in a pET plasmidLMoveover, the truncated
Vmp protein is soluble and it can be readily purified to homogeneity without the use of detergents.
1 Duray, P., Lade, B.N. and Dunn, JJ. (unpuplished).
2 Barbour, A.G. (personal communication).
3 Bundoc, V.G., Barbour, A.G., Lade, B.N. and Dunn, JJ. (unpublished)
62
SUMMARY
The T7 based pET expression system is a powerful and versatile system for cloning and expression of
recombinant proteins in E. coli. PCR technology complements the pET system since it permits precise, sequence
specific amplification of coding sequences which, when used in conjunction with appropriately designed primers
allows amplification of DNA tailored for direct insertion into a pET vector. The net result is a more highly
efficient method to rationally engineer and express open reading frames. In certain instances, the target protein
may contain sequences which limit overproduction. If the sequence is a specific domain of the target protein
then it may be possible to remove it without destroying the protein per say. A good example of such a domain
is the class of hydrophobic leader signal sequences found at the beginning of Borrelia lipoproteins (OspA, OspB
and the Vmp's). Elevated expression of the full-length proteins is toxic to the overproducing strains and they
stop making the protein after a short period of time. In contrast, these same proteins without the hydrophobic
leader sequences continue to be synthesized at high rates for hours following induction and they accumulate to
very high levels. The ability to produce these recombinant proteins in large amounts and in a highly purified
state without using detergents raises the possibility that they may be useful in immunoassays and as possible
immunogens in vaccines. Such studies are currently in progress.
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